1. Home
  2. TRML vs IMKTA Comparison

TRML vs IMKTA Comparison

Compare TRML & IMKTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRML
  • IMKTA
  • Stock Information
  • Founded
  • TRML 2021
  • IMKTA 1963
  • Country
  • TRML United States
  • IMKTA United States
  • Employees
  • TRML N/A
  • IMKTA N/A
  • Industry
  • TRML Biotechnology: Pharmaceutical Preparations
  • IMKTA Food Chains
  • Sector
  • TRML Health Care
  • IMKTA Consumer Staples
  • Exchange
  • TRML Nasdaq
  • IMKTA Nasdaq
  • Market Cap
  • TRML 1.2B
  • IMKTA 1.3B
  • IPO Year
  • TRML N/A
  • IMKTA N/A
  • Fundamental
  • Price
  • TRML $47.90
  • IMKTA $71.17
  • Analyst Decision
  • TRML Hold
  • IMKTA
  • Analyst Count
  • TRML 12
  • IMKTA 0
  • Target Price
  • TRML $47.04
  • IMKTA N/A
  • AVG Volume (30 Days)
  • TRML 957.5K
  • IMKTA 108.9K
  • Earning Date
  • TRML 11-06-2025
  • IMKTA 08-07-2025
  • Dividend Yield
  • TRML N/A
  • IMKTA 0.94%
  • EPS Growth
  • TRML N/A
  • IMKTA N/A
  • EPS
  • TRML N/A
  • IMKTA 2.97
  • Revenue
  • TRML N/A
  • IMKTA $5,363,138,171.00
  • Revenue This Year
  • TRML N/A
  • IMKTA N/A
  • Revenue Next Year
  • TRML N/A
  • IMKTA N/A
  • P/E Ratio
  • TRML N/A
  • IMKTA $24.01
  • Revenue Growth
  • TRML N/A
  • IMKTA N/A
  • 52 Week Low
  • TRML $11.56
  • IMKTA $58.92
  • 52 Week High
  • TRML $48.27
  • IMKTA $75.63
  • Technical
  • Relative Strength Index (RSI)
  • TRML 91.37
  • IMKTA 58.79
  • Support Level
  • TRML $47.83
  • IMKTA $68.30
  • Resistance Level
  • TRML $47.94
  • IMKTA $72.87
  • Average True Range (ATR)
  • TRML 0.11
  • IMKTA 1.69
  • MACD
  • TRML -0.63
  • IMKTA 0.06
  • Stochastic Oscillator
  • TRML 38.14
  • IMKTA 68.42

About TRML Tourmaline Bio Inc.

Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.

About IMKTA Ingles Markets Incorporated

Ingles Markets Inc is a U.S.-based company that is principally engaged in operating a supermarket chain. The company operates the business in the southeast United States, mainly in Georgia, North Carolina, South Carolina, and Tennessee, with a few stores in Virginia and Alabama as well. The company locates its stores majorly in suburban areas, small towns, and neighborhood areas. It offers a broad range of goods, including food products, pharmacies, health and beauty care products, and general merchandise. The retail business contributes the majority of the company's revenue. The company's real estate ownership of a material portion of total stores enables it to generate rental income.

Share on Social Networks: